In early 2017, the price platform Castlight Health made a strategic acquisition of Jiff for $135 million. Jiff mainly provides a platform called Health Outcomes Marketplace. This platform provides one-stop health management for business employees, who can access any wearable device and app available on the market to manage their own data, fitness and treatment options. The employer of the enterprise gives certain incentives based on the performance of the employee on this platform. For example, the employee can reduce the deductible portion of the commercial medical insurance. There are already dozens of large companies that have become Jiff's customers, the largest of which has 50,000 employees. Jiff will provide free equipment to the user, but will charge the employer accordingly. Since the United States launched the parity bill, US payers of medical institutions began to try not to but in the number of medical value to calculate the amount of damages, which means that doctors need to help patients prevent and control the disease. For business employers, the logic behind them is the same. The annual insurance premium paid by the employer to the insurance company is calculated based on the loss rate of the previous year. The higher the employee's sickness expenditure, the higher the premium paid by the employer. Therefore, employers in the United States have a strong incentive to control employees to reduce the incidence of disease, which also finds the payer for the service to improve the health of employees. The services provided by Jiff are actually used by employees who integrate wearable devices and apps from all markets into one platform and provide them to the platform for free. This model has mixed advantages for wearable device vendors. The benefit is the ability to ship quickly and in large quantities to boost your revenue. The downside is that most of the equipment will eventually be eliminated, because the company's employees must choose products with more comprehensive performance and features, so that the stronger the stronger. Moreover, when the platform model firmly controls the market, the existence of the wearable device manufacturer will lose its meaning, the individual no longer needs to purchase in the market, and the platform provider can completely customize the product according to the user's needs to the wearable device. The manufacturer provides the order. But even with this direct-to-employer-oriented business model, its growth is still quite limited. Compared with Teladoc, a model that relies on remote consultation to help payers directly control fees, the effect of employee health management is difficult to reflect in the short term. It is also impossible to obtain large-scale market development in the short term. The main reason here is that users often change insurance companies. American employers often change one insurance service provider within one to two years, and digital medical tools are difficult to show the effect of cost control within one or two years. In short, if you insist that running every day can reduce a person's risk of heart disease by 30% after 10 years, it is 10 years later, and that 30% is also uncertain, or difficult to quantify, can not be to the insurance company. Short-term costs have an impact. As a result, insurers are becoming more and more practical, and the management of healthy and sub-healthy people does not see any effect in the short term, and the health expenditures of healthy people are inherently low.
Organic raw materials refer to the petrochemical industry that uses petroleum and natural gas as raw materials, and the industry to produce or fractionate various organic Chemical Products from the raw material gas after coal gasification and the coal tar recovered by dry distillation from grain fermentation to produce alcohol or solvent. In my country's organic chemical industry, the route of producing acetylene from calcium carbide from coal, the route of coal gasification to synthesize methanol and formaldehyde, the route of recovering benzene, naphthalene, and anthracene from coal tar, and the route of fermenting and distilling grains as raw materials to produce alcohol were developed.
We are a biotechnology company in pharmaceutical raw materials production research and development, We had passed FDA certificate and ISO 9001 .we have enough experience, our company has the GMP production workshop and standard plant extraction equipment dozens of Taiwan, starting in 2012, in response to increase export of national policy, our company started drug raw materials exports, at present, the company has 50 people the size of the foreign trade sales team, Annual sales are $30 million. We can produce high quality of Vitamin Products , at the same time, we are factory price of Vitamin K2 Powder, extracted by professional production equipment, can produce supply Vitamin And Enzyme, 2-Benzoxazolinone,Bismuth Subsalicylate,2-ISOPROPYLANILINE,Zinc Chloride,2-Phenoxyethylbromide Xi'an Henrikang Biotech Co.,Ltd , https://www.henrikangbio.com
In accord with national qualification, after we have made the corresponding qualifications, Human Api Product can supply for overseas customers a reasonable price products At the same time, we increase research in men's health, the production of Sex Enhancement Powder, to help the majority of male friends get rid of trouble, get rid of trouble. We also have a mature production process to meet the needs of our customers. The quality and price of our Healthcare Product make us our flagship product. We also provide weight loss related ingredients, Orlistat is our best-selling weight loss product.